Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Pritesh Mehta of IIFL, one can buy Mahindra Ugine and Sun Pharmaceutical Industries.
With Autoline Industries ruling at Rs 79-80, one may get a price target of Rs 100 in next six months, says SP Tulsian of sptulsian.com.
Rajesh Agarwal of Eastern Financiers recommends buying Mahindra Ugine Steel Company, Rasoya Proteins, Welspun Corp and Ipca Laboratories.
Rajesh Agarwal of Eastern Financiers advises to buy Mahindra Ugine for a target price of Rs 95.50 and Rasoya Proteins for a target price of Rs 13.
Rajesh Agarwal of Eastern Financiers suggests buying Mahindra Ugine Steel Company, IVRCL, Lakshmi Vilas Bank and Alembic Pharmaceuticals.
Rajesh Agarwal of Eastern Financiers advised buying Mahindra Ugine for a target price of Rs 93 and IVRCL for a price target of Rs 17.50.
Rajesh Agarwal of Eastern Financiers advises buying Mahindra Ugine, Panacea Bioetc, Financial Technologies, Essdee Aluminium.
Rajesh Agarwal of Eastern Financiers advises buying Mahindra Ugine for a target price of Rs 85 and Panacea Biotec for a target price of Rs 135.
Rajesh Agarwal of Eastern Financiers recommends buying Mahindra Ugine, Polaris Financial Technology, SREI Infrastructure and Orchid Chemicals.
Rajesh Agarwal of Eastern Financiers recommended to buy Mahindra Ugine for a target price of Rs 77 and buy Polaris for a target price of Rs 127.
SP Tulsian of sptulsian.com is positive on Mahindra Ugine. He feels the stock may move to a level of Rs 130-150 and this phenomenon will continue for quite some time.
Rajesh Agarwal of Eastern Financiers recommends buying Oil India, Tata Coffee and Lanco Infratech.
Rajesh Agarwal of Eastern Financiers advised buying Mahindra Group's Mahindra Ugine with a stoploss at Rs 62 and for a target price of Rs 69.
Mahindra Ugine Steel Company will go and test Rs 80-82 from next six to eight months perspective, says Aashish Tater, Head of Research of www.fortunewizard.com.
See 100% upside in Mahindra Ugine Steel Company, says Rajen Shah, Angel Broking. Its stamping business is a highly profitable business. It has got about 3-4 units and it is currently operating at about 100 percent capacity.
Rajen Shah, CIO, Angel Broking is bullish on Mahindra Ugine from a little longer term perspective. He thinks it’s a sure multi-bagger in the making.
SP Tulsian of sptulsian.com has recommended investing in Mahindra Ugine with long term view.
Mahindra Ugine can move to Rs 80-90 in a year, says SP Tulsian, sptulsian.com.